European Commission Approves LEO Pharma’s Anzupgo® (delgocitinib) Cream for Adults with Moderate to Severe Chronic Hand ...
LEO Pharma A/S, a global leader in medical dermatology, announced that the European Commission (EC) has granted marketing authorization for Anzupgo (delgocitinib) cream for the treatment of adult ...
LEO Pharma Unveils Most Extensive EADV Program To Date with 5 Late Breaking Abstracts and 23 Posters Sharing Clinical and ...
The Food and Drug Administration had recently approved a new drug for the treatment of atopic dermatitis (eczema), which can ...
Jefferies analyst Michael Yee in a note to investors called rocatinlimab’s atopic dermatitis data “modest,” noting that the ...
A mom is raising awareness by sharing pictures of her eleven-year-old daughter's eczema - which has caused pain, itching, and ...
The Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for delgocitinib cream as a treatment for moderate to severe chronic hand eczema in adults who have had an ...
According to the NHS, eczema is a common skin condition that causes dry and itchy rashes. Currently, in the UK around 1.5 million adults have eczema, which amounts to 3% of the population. Skincare ...
Taking care of your child's skin can be challenging as it is delicate and sensitive to environmental factors like weather and ...
Eczemas in the elderly often arise mysteriously and itch furiously. New-onset, otherwise unexplained eczema that cannot be attributed to atopic disease, irritant or allergic contact dermatitis ...